{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:59:18Z","timestamp":1790265558916,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T00:00:00Z","timestamp":1344297600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1038\/bjc.2012.348","type":"journal-article","created":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T20:18:24Z","timestamp":1344370704000},"page":"904-909","source":"Crossref","is-referenced-by-count":98,"title":["Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study"],"prefix":"10.1038","volume":"107","author":[{"given":"F","family":"Efficace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Baccarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Rosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Cottone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Castagnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Breccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Alimena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Iurlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A R","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Gherlinzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Salvucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tiribelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Vignetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Mandelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,7]]},"reference":[{"key":"BFbjc2012348_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.5993\/AJHB.33.2.5","volume":"33","author":"JE Banta","year":"2009","unstructured":"Banta JE, Haskard KB, Haviland MG, Williams SL, Werner LS, Anderson DL, DiMatteo MR (2009) Mental health, binge drinking, and antihypertension medication adherence. Am J Health Behav 33: 158\u2013171","journal-title":"Am J Health Behav"},{"issue":"2","key":"BFbjc2012348_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2010.10.018","volume":"300","author":"M Breccia","year":"2011","unstructured":"Breccia M, Efficace F, Alimena G (2011) Imatinib treatment in chronic myelogenous leukemia: What have we learned so far? Cancer Lett 300 (2): 115\u2013121","journal-title":"Cancer Lett"},{"key":"BFbjc2012348_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1037\/0278-6133.23.2.207","volume":"23","author":"MR DiMatteo","year":"2004","unstructured":"DiMatteo MR (2004a) Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 23: 207\u2013218","journal-title":"Health Psychol"},{"key":"BFbjc2012348_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","volume":"42","author":"MR DiMatteo","year":"2004","unstructured":"DiMatteo MR (2004b) Variations in patients\u2019 adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 42: 200\u2013209","journal-title":"Med Care"},{"key":"BFbjc2012348_CR5","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1182\/blood-2011-04-347575","volume":"118","author":"F Efficace","year":"2011","unstructured":"Efficace F, Baccarani M, Breccia M, Alimena G, Rosti G, Cottone F, Deliliers GL, Barate C, Rossi AR, Fioritoni G, Luciano L, Turri D, Martino B, Di Raimondo F, Dabusti M, Bergamaschi M, Leoni P, Simula MP, Levato L, Ulisciani S, Veneri D, Sica S, Rambaldi A, Vignetti M, Mandelli F (2011) Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population. Blood 118: 4554\u20134560","journal-title":"Blood"},{"issue":"S2","key":"BFbjc2012348_CR6","first-page":"189","volume":"95","author":"F Efficace","year":"2010","unstructured":"Efficace F, Breccia M, Baccarani M, Alimena G, Lambertenghi Deliliers G, Specchia G, Cottone F, Vignetti M, Mandelli F (2010) Development and feasibility of a patient-reported symptom checklist for chronic myeloid leukemia patients. Haematologica 95 (S2): 189","journal-title":"Haematologica"},{"key":"BFbjc2012348_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.critrevonc.2011.02.007","volume":"81","author":"F Efficace","year":"2012","unstructured":"Efficace F, Cocks K, Breccia M, Sprangers M, Meyers CA, Vignetti M, Baccarani M, Mandelli F (2012) Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: inclusion of quality of life and other patient-reported outcomes. Crit Rev Oncol\/Hemat 81: 123\u2013135","journal-title":"Crit Rev Oncol\/Hemat"},{"key":"BFbjc2012348_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-4541-9","volume-title":"An Introduction to the Bootstrap","author":"B Efron","year":"1993","unstructured":"Efron B, Tibshirani R (1993) An Introduction to the Bootstrap. Chapman and Hall: London"},{"key":"BFbjc2012348_CR9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.leukres.2010.10.017","volume":"35","author":"L Eliasson","year":"2011","unstructured":"Eliasson L, Clifford S, Barber N, Marin D (2011) Exploring chronic myeloid leukemia patients\u2019 reasons for not adhering to the oral anticancer drug imatinib as prescribed. Leuk Res 35: 626\u2013630","journal-title":"Leuk Res"},{"key":"BFbjc2012348_CR10","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1097\/00002030-199909100-00021","volume":"13","author":"V Gordillo","year":"1999","unstructured":"Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J (1999) Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 13: 1763\u20131769","journal-title":"AIDS"},{"key":"BFbjc2012348_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1477-7525-4-88","volume":"4","author":"E Grossi","year":"2006","unstructured":"Grossi E, Groth N, Mosconi P, Cerutti R, Pace F, Compare A, Apolone G (2006) Development and validation of the short version of the Psychological General Well-Being Index (PGWB-S). Health Qual Life Outcomes 4: 88","journal-title":"Health Qual Life Outcomes"},{"key":"BFbjc2012348_CR12","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1200\/JCO.2003.12.154","volume":"21","author":"EA Hahn","year":"2003","unstructured":"Hahn EA, Glendenning GA, Sorensen MV, Hudgens SA, Druker BJ, Guilhot F, Larson RA, O\u2019Brien SG, Dobrez DG, Hensley ML, Cella D (2003) Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study. J Clin Oncol 21: 2138\u20132146","journal-title":"J Clin Oncol"},{"key":"BFbjc2012348_CR13","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1182\/blood-2010-10-309807","volume":"117","author":"AR Ibrahim","year":"2011","unstructured":"Ibrahim AR, Eliasson L, Apperley JF, Milojkovic D, Bua M, Szydlo R, Mahon FX, Kozlowski K, Paliompeis C, Foroni L, Khorashad JS, Bazeos A, Molimard M, Reid A, Rezvani K, Gerrard G, Goldman J, Marin D (2011) Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. Blood 117: 3733\u20133736","journal-title":"Blood"},{"key":"BFbjc2012348_CR14","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jama.288.4.462","volume":"288","author":"CA Jackevicius","year":"2002","unstructured":"Jackevicius CA, Mamdani M, Tu JV (2002) Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288: 462\u2013467","journal-title":"JAMA"},{"key":"BFbjc2012348_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00277-011-1359-0","volume":"91","author":"S Jonsson","year":"2012","unstructured":"Jonsson S, Olsson B, Soderberg J, Wadenvik H (2012) Good adherence to imatinib therapy among patients with chronic myeloid leukemia-a single-center observational study. Ann Hematol 91: 679\u2013685","journal-title":"Ann Hematol"},{"key":"BFbjc2012348_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1001\/archinte.167.6.540","volume":"167","author":"S Kripalani","year":"2007","unstructured":"Kripalani S, Yao X, Haynes RB (2007) Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 167: 540\u2013550","journal-title":"Arch Intern Med"},{"key":"BFbjc2012348_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/01.hco.0000126978.03828.9e","volume":"19","author":"M Krousel-Wood","year":"2004","unstructured":"Krousel-Wood M, Thomas S, Muntner P, Morisky D (2004) Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 19: 357\u2013362","journal-title":"Curr Opin Cardiol"},{"key":"BFbjc2012348_CR18","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/01.psy.0000188393.73571.0a","volume":"67","author":"HS Lett","year":"2005","unstructured":"Lett HS, Blumenthal JA, Babyak MA, Strauman TJ, Robins C, Sherwood A (2005) Social support and coronary heart disease: epidemiologic evidence and implications for treatment. Psychosom Med 67: 869\u2013878","journal-title":"Psychosom Med"},{"key":"BFbjc2012348_CR19","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1200\/JCO.2009.26.3087","volume":"28","author":"D Marin","year":"2010","unstructured":"Marin D, Bazeos A, Mahon FX, Eliasson L, Milojkovic D, Bua M, Apperley JF, Szydlo R, Desai R, Kozlowski K, Paliompeis C, Latham V, Foroni L, Molimard M, Reid A, Rezvani K, de Lavallade H, Guallar C, Goldman J, Khorashad JS (2010) Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. J Clin Oncol 28: 2381\u20132388","journal-title":"J Clin Oncol"},{"key":"BFbjc2012348_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1158\/1940-6207.CAPR-11-0442","volume":"5","author":"A Markkula","year":"2012","unstructured":"Markkula A, Hietala M, Henningson M, Ingvar C, Rose C, Jernstrom H (2012) Clinical profiles predict early nonadherence to adjuvant endocrine treatment in a prospective breast cancer cohort. Cancer Prev Res 5: 735\u2013745","journal-title":"Cancer Prev Res"},{"key":"BFbjc2012348_CR21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s12032-011-9926-8","volume":"29","author":"JH Moon","year":"2011","unstructured":"Moon JH, Sohn SK, Kim SN, Park SY, Yoon SS, Kim IH, Kim HJ, Kim YK, Min YH, Cheong JW, Kim JS, Jung CW, Kim DH (2011) Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients. Med Oncol 29: 1179\u20131185","journal-title":"Med Oncol"},{"key":"BFbjc2012348_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","volume":"10","author":"DE Morisky","year":"2008","unstructured":"Morisky DE, Ang A, Krousel-Wood M, Ward HJ (2008) Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 10: 348\u2013354","journal-title":"J Clin Hypertens"},{"key":"BFbjc2012348_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jclinepi.2010.09.002","volume":"64","author":"DE Morisky","year":"2011","unstructured":"Morisky DE, DiMatteo MR (2011) Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol 64: 255\u2013257, discussion 258\u2013263","journal-title":"J Clin Epidemiol"},{"key":"BFbjc2012348_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","volume":"24","author":"DE Morisky","year":"1986","unstructured":"Morisky DE, Green LW, Levine DM (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24: 67\u201374","journal-title":"Med Care"},{"key":"BFbjc2012348_CR25","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1182\/blood-2008-12-196543","volume":"113","author":"L Noens","year":"2009","unstructured":"Noens L, van Lierde MA, De Bock R, Verhoef G, Zachee P, Berneman Z, Martiat P, Mineur P, Van Eygen K, MacDonald K, De Geest S, Albrecht T, Abraham I (2009) Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood 113: 5401\u20135411","journal-title":"Blood"},{"key":"BFbjc2012348_CR26","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1056\/NEJMoa022457","volume":"348","author":"SG O\u2019Brien","year":"2003","unstructured":"O\u2019Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T, Lechner K, Nielsen JL, Rousselot P, Reiffers J, Saglio G, Shepherd J, Simonsson B, Gratwohl A, Goldman JM, Kantarjian H, Taylor K, Verhoef G, Bolton AE, Capdeville R, Druker BJ (2003) Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 348: 994\u20131004","journal-title":"N Engl J Med"},{"key":"BFbjc2012348_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353: 487\u2013497","journal-title":"N Engl J Med"},{"key":"BFbjc2012348_CR28","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/jnci\/94.9.652","volume":"94","author":"AH Partridge","year":"2002","unstructured":"Partridge AH, Avorn J, Wang PS, Winer EP (2002) Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94: 652\u2013661","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2012348_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1200\/JCO.1990.8.2.356","volume":"8","author":"JL Richardson","year":"1990","unstructured":"Richardson JL, Shelton DR, Krailo M, Levine AM (1990) The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol 8: 356\u2013364","journal-title":"J Clin Oncol"},{"key":"BFbjc2012348_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10654-010-9432-x","volume":"25","author":"R Risselada","year":"2010","unstructured":"Risselada R, Lingsma HF, Bauer-Mehren A, Friedrich CM, Molyneux AJ, Kerr RS, Yarnold J, Sneade M, Steyerberg EW, Sturkenboom MC (2010) Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT). Eur J Epidemiol 25: 261\u2013266","journal-title":"Eur J Epidemiol"},{"key":"BFbjc2012348_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3322\/caac.20004","volume":"59","author":"K Ruddy","year":"2009","unstructured":"Ruddy K, Mayer E, Partridge A (2009) Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 59: 56\u201366","journal-title":"CA Cancer J Clin"},{"key":"BFbjc2012348_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1477-7525-8-99","volume":"8","author":"L Shi","year":"2010","unstructured":"Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M (2010) Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes 8: 99","journal-title":"Health Qual Life Outcomes"},{"key":"BFbjc2012348_CR33","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","volume":"54","author":"EW Steyerberg","year":"2001","unstructured":"Steyerberg EW, Harrell FE, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD (2001) Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54: 774\u2013781","journal-title":"J Clin Epidemiol"},{"key":"BFbjc2012348_CR34","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jclinepi.2009.10.008","volume":"63","author":"E Suarthana","year":"2010","unstructured":"Suarthana E, Vergouwe Y, Moons KG, de Monchy J, Grobbee D, Heederik D, Meijer E (2010) A diagnostic model for the detection of sensitization to wheat allergens was developed and validated in bakery workers. J Clin Epidemiol 63: 1011\u20131019","journal-title":"J Clin Epidemiol"},{"key":"BFbjc2012348_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","volume":"26","author":"E Vermeire","year":"2001","unstructured":"Vermeire E, Hearnshaw H, Van Royen P, Denekens J (2001) Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 26: 331\u2013342","journal-title":"J Clin Pharm Ther"},{"key":"BFbjc2012348_CR36","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","volume":"73","author":"B Vrijens","year":"2012","unstructured":"Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, Dobbels F, Fargher E, Morrison V, Lewek P, Matyjaszczyk M, Mshelia C, Clyne W, Aronson JK, Urquhart J (2012) A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 73: 691\u2013705","journal-title":"Br J Clin Pharmacol"},{"key":"BFbjc2012348_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473\u2013483","journal-title":"Med Care"},{"key":"BFbjc2012348_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Wester K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia \u2013related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symp Manage 13: 63\u201374","journal-title":"J Pain Symp Manage"},{"key":"BFbjc2012348_CR39","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1080\/00223891.1990.9674095","volume":"55","author":"GD Zimet","year":"1990","unstructured":"Zimet GD, Powell SS, Farley GK, Werkman S, Berkoff KA (1990) Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. J Pers Assess 55: 610\u2013617","journal-title":"J Pers Assess"},{"key":"BFbjc2012348_CR40","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/MLR.0b013e31819a5acc","volume":"47","author":"KB Zolnierek","year":"2009","unstructured":"Zolnierek KB, Dimatteo MR (2009) Physician communication and patient adherence to treatment: a meta-analysis. Med Care 47: 826\u2013834","journal-title":"Med Care"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2012348.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012348","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012348.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:09:45Z","timestamp":1684415385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2012348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,7]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["BFbjc2012348"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2012.348","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,7]]}}}